Stockreport

ARS Pharmaceuticals Inc (SPRY) Q4 2025 Earnings Call Highlights: Strong Market Entry and ... [Yahoo! Finance]

ARS Pharmaceuticals, Inc.  (SPRY) 
PDF This article first appeared on GuruFocus Net Product Revenue: $72.2 million for the first full year of commercial sales. Total Revenue: $84.3 million, including col [Read more]